| 0 |
BRIEF PSYCHOTIC DISORDER WITHOUT MARKED STRESSORS |
1 |
0.2500 |
| 1 |
CORONARY STEAL SYNDROME |
3 |
0.2000 |
| 2 |
RADIOISOTOPE UPTAKE INCREASED |
4 |
0.0909 |
| 3 |
CARDIAC PERFUSION DEFECT |
4 |
0.0755 |
| 4 |
ACTIVITIES OF DAILY LIVING ASSESSMENT |
1 |
0.0500 |
| 5 |
JOINT VIBRATION |
1 |
0.0476 |
| 6 |
HEMIPLEGIC MIGRAINE |
11 |
0.0324 |
| 7 |
CARDIAC IMAGING PROCEDURE ABNORMAL |
1 |
0.0238 |
| 8 |
INTESTINAL ANGINA |
1 |
0.0238 |
| 9 |
SCROTAL GANGRENE |
1 |
0.0233 |
| 10 |
CORONARY VASCULAR GRAFT OCCLUSION |
1 |
0.0227 |
| 11 |
ACQUIRED LEFT VENTRICLE OUTFLOW TRACT OBSTRUCTION |
1 |
0.0204 |
| 12 |
THERAPEUTIC PRODUCT EFFECT PROLONGED |
9 |
0.0199 |
| 13 |
RADIATION OVERDOSE |
1 |
0.0185 |
| 14 |
EXERCISE ELECTROCARDIOGRAM ABNORMAL |
1 |
0.0120 |
| 15 |
VENTRICULAR DYSSYNCHRONY |
1 |
0.0090 |
| 16 |
CARDIAC STRESS TEST |
1 |
0.0079 |
| 17 |
ALKALOSIS HYPOCHLORAEMIC |
1 |
0.0071 |
| 18 |
SCAN MYOCARDIAL PERFUSION ABNORMAL |
1 |
0.0065 |
| 19 |
PHLEBOLITH |
1 |
0.0059 |
| 20 |
VENTRICULAR ASYSTOLE |
1 |
0.0057 |
| 21 |
PITUITARY APOPLEXY |
1 |
0.0057 |
| 22 |
MALIGNANT NEOPLASM OF SPINAL CORD |
1 |
0.0055 |
| 23 |
CELLULITIS GANGRENOUS |
1 |
0.0051 |
| 24 |
CARDIAC SARCOIDOSIS |
1 |
0.0043 |
| 25 |
CYANOSIS CENTRAL |
1 |
0.0038 |
| 26 |
CSF PRESSURE INCREASED |
1 |
0.0038 |
| 27 |
WRONG PRODUCT STORED |
1 |
0.0035 |
| 28 |
GASTROINTESTINAL ARTERIOVENOUS MALFORMATION |
1 |
0.0034 |
| 29 |
NODAL RHYTHM |
5 |
0.0034 |
| 30 |
SINOATRIAL BLOCK |
2 |
0.0034 |
| 31 |
ELECTROCARDIOGRAM QRS COMPLEX ABNORMAL |
1 |
0.0031 |
| 32 |
KOUNIS SYNDROME |
7 |
0.0031 |
| 33 |
GENITAL INFECTION |
1 |
0.0030 |
| 34 |
BLOOD VISCOSITY DECREASED |
1 |
0.0030 |
| 35 |
PSEUDOSTROKE |
1 |
0.0029 |
| 36 |
LEFT VENTRICLE OUTFLOW TRACT OBSTRUCTION |
1 |
0.0029 |
| 37 |
WOUND ABSCESS |
1 |
0.0029 |
| 38 |
DILATATION VENTRICULAR |
6 |
0.0029 |
| 39 |
SMALL CELL LUNG CANCER METASTATIC |
1 |
0.0028 |
| 40 |
ELECTROCARDIOGRAM ST SEGMENT DEPRESSION |
6 |
0.0027 |
| 41 |
IMMEDIATE POST-INJECTION REACTION |
3 |
0.0027 |
| 42 |
AXILLARY VEIN THROMBOSIS |
1 |
0.0027 |
| 43 |
SCROTAL ABSCESS |
1 |
0.0026 |
| 44 |
MYOCARDIAL OEDEMA |
1 |
0.0025 |
| 45 |
GENITAL ABSCESS |
1 |
0.0025 |
| 46 |
DEVICE COLOUR ISSUE |
1 |
0.0025 |
| 47 |
ELECTROCARDIOGRAM ST SEGMENT ELEVATION |
8 |
0.0024 |
| 48 |
VASCULAR STENT STENOSIS |
1 |
0.0024 |
| 49 |
ARTERIOSPASM CORONARY |
9 |
0.0022 |
| 50 |
PERINEAL ABSCESS |
1 |
0.0022 |
| 51 |
ADRENAL NEOPLASM |
1 |
0.0021 |
| 52 |
BUNDLE BRANCH BLOCK LEFT |
9 |
0.0021 |
| 53 |
BRAIN STEM STROKE |
1 |
0.0020 |
| 54 |
SENSORIMOTOR DISORDER |
1 |
0.0020 |
| 55 |
FALSE POSITIVE INVESTIGATION RESULT |
2 |
0.0020 |
| 56 |
PATELLOFEMORAL PAIN SYNDROME |
1 |
0.0019 |
| 57 |
DEVICE USE CONFUSION |
1 |
0.0019 |
| 58 |
DEVICE CONNECTION ISSUE |
4 |
0.0019 |
| 59 |
CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER |
2 |
0.0019 |
| 60 |
BLOOD MAGNESIUM ABNORMAL |
1 |
0.0018 |
| 61 |
INTENTION TREMOR |
1 |
0.0018 |
| 62 |
MEDIASTINITIS |
1 |
0.0017 |
| 63 |
MEAN PLATELET VOLUME INCREASED |
1 |
0.0017 |
| 64 |
CARDIAC PROCEDURE COMPLICATION |
1 |
0.0016 |
| 65 |
ATRIOVENTRICULAR BLOCK |
12 |
0.0016 |
| 66 |
ENTEROCOCCUS TEST POSITIVE |
1 |
0.0015 |
| 67 |
KLEBSIELLA TEST POSITIVE |
1 |
0.0015 |
| 68 |
ACUTE LEFT VENTRICULAR FAILURE |
1 |
0.0015 |
| 69 |
RADIOISOTOPE SCAN ABNORMAL |
1 |
0.0014 |
| 70 |
BORDERLINE PERSONALITY DISORDER |
1 |
0.0014 |
| 71 |
ALANINE AMINOTRANSFERASE DECREASED |
1 |
0.0014 |
| 72 |
BLOOD BILIRUBIN UNCONJUGATED INCREASED |
1 |
0.0014 |
| 73 |
ISCHAEMIA |
6 |
0.0013 |
| 74 |
SINUS ARREST |
2 |
0.0013 |
| 75 |
PRODUCT PACKAGING CONFUSION |
3 |
0.0012 |
| 76 |
CARDIAC STRESS TEST ABNORMAL |
1 |
0.0012 |
| 77 |
LIP PRURITUS |
1 |
0.0012 |
| 78 |
ALLERGIC SINUSITIS |
1 |
0.0012 |
| 79 |
ARTERIAL STENOSIS |
1 |
0.0011 |
| 80 |
UNRESPONSIVE TO STIMULI |
29 |
0.0011 |
| 81 |
ELECTROCARDIOGRAM CHANGE |
1 |
0.0011 |
| 82 |
PULSE ABSENT |
5 |
0.0011 |
| 83 |
FACIAL ASYMMETRY |
1 |
0.0010 |
| 84 |
NEUROMYOPATHY |
1 |
0.0009 |
| 85 |
RIGHT VENTRICULAR DYSFUNCTION |
1 |
0.0009 |
| 86 |
FACIAL SPASM |
1 |
0.0009 |
| 87 |
BLOOD FIBRINOGEN DECREASED |
1 |
0.0009 |
| 88 |
PELVIC ABSCESS |
1 |
0.0009 |
| 89 |
GROIN ABSCESS |
1 |
0.0008 |
| 90 |
CONTRAST MEDIA REACTION |
2 |
0.0008 |
| 91 |
LABILE BLOOD PRESSURE |
1 |
0.0008 |
| 92 |
CHRONIC RESPIRATORY FAILURE |
1 |
0.0008 |
| 93 |
HYPERPARATHYROIDISM SECONDARY |
2 |
0.0008 |
| 94 |
BENIGN INTRACRANIAL HYPERTENSION |
1 |
0.0008 |
| 95 |
PHLEBITIS |
4 |
0.0008 |
| 96 |
CULTURE URINE POSITIVE |
1 |
0.0007 |
| 97 |
MUTISM |
1 |
0.0007 |
| 98 |
STRESS CARDIOMYOPATHY |
4 |
0.0007 |
| 99 |
GENERALISED ANXIETY DISORDER |
1 |
0.0007 |
| 100 |
SECONDARY ADRENOCORTICAL INSUFFICIENCY |
1 |
0.0007 |
| 101 |
ATRIOVENTRICULAR BLOCK SECOND DEGREE |
2 |
0.0007 |
| 102 |
COAGULATION TIME PROLONGED |
1 |
0.0006 |
| 103 |
MYOCARDIAL ISCHAEMIA |
7 |
0.0006 |
| 104 |
INJECTION RELATED REACTION |
1 |
0.0006 |
| 105 |
MEAN CELL HAEMOGLOBIN INCREASED |
1 |
0.0006 |
| 106 |
RESUSCITATION |
1 |
0.0006 |
| 107 |
TROPONIN I INCREASED |
1 |
0.0006 |
| 108 |
COLITIS ISCHAEMIC |
4 |
0.0006 |
| 109 |
FANCONI SYNDROME ACQUIRED |
1 |
0.0006 |
| 110 |
TYPE I HYPERSENSITIVITY |
2 |
0.0006 |
| 111 |
ESSENTIAL HYPERTENSION |
1 |
0.0005 |
| 112 |
SINUS NODE DYSFUNCTION |
1 |
0.0005 |
| 113 |
CONTRAST MEDIA ALLERGY |
1 |
0.0005 |
| 114 |
CONDUCTION DISORDER |
1 |
0.0005 |
| 115 |
VENTRICULAR FIBRILLATION |
6 |
0.0005 |
| 116 |
HYPERCOAGULATION |
1 |
0.0005 |
| 117 |
CARDIAC DISCOMFORT |
1 |
0.0005 |
| 118 |
LIPIDS INCREASED |
1 |
0.0005 |
| 119 |
BREAST DISORDER |
1 |
0.0005 |
| 120 |
PULSELESS ELECTRICAL ACTIVITY |
2 |
0.0005 |
| 121 |
ACUTE MYOCARDIAL INFARCTION |
14 |
0.0005 |
| 122 |
NEUROGENIC BLADDER |
1 |
0.0005 |
| 123 |
PHARYNGEAL ERYTHEMA |
1 |
0.0005 |
| 124 |
BRADYCARDIA |
25 |
0.0005 |
| 125 |
POOR PERIPHERAL CIRCULATION |
2 |
0.0005 |
| 126 |
HYPERPHOSPHATAEMIA |
1 |
0.0005 |
| 127 |
VITREOUS DETACHMENT |
1 |
0.0005 |
| 128 |
ATRIOVENTRICULAR BLOCK COMPLETE |
3 |
0.0004 |
| 129 |
BLOOD PRESSURE SYSTOLIC DECREASED |
2 |
0.0004 |
| 130 |
EYE MOVEMENT DISORDER |
3 |
0.0004 |
| 131 |
NEPHROGENIC ANAEMIA |
2 |
0.0004 |
| 132 |
SUPRAVENTRICULAR TACHYCARDIA |
4 |
0.0004 |
| 133 |
STARING |
1 |
0.0004 |
| 134 |
RESPIRATORY DEPRESSION |
5 |
0.0004 |
| 135 |
MENTAL STATUS CHANGES |
11 |
0.0004 |
| 136 |
MEAN CELL VOLUME INCREASED |
1 |
0.0004 |
| 137 |
VENTRICULAR EXTRASYSTOLES |
4 |
0.0004 |
| 138 |
BLOOD POTASSIUM ABNORMAL |
1 |
0.0004 |
| 139 |
BLOOD PRESSURE FLUCTUATION |
9 |
0.0004 |
| 140 |
PRESYNCOPE |
9 |
0.0004 |
| 141 |
PLEURITIC PAIN |
1 |
0.0004 |
| 142 |
PRODUCT LEAKAGE |
2 |
0.0004 |
| 143 |
BRONCHOSPASM |
5 |
0.0004 |
| 144 |
CARDIOGENIC SHOCK |
5 |
0.0003 |
| 145 |
VOMITING PROJECTILE |
1 |
0.0003 |
| 146 |
BILIARY COLIC |
1 |
0.0003 |
| 147 |
DYSAESTHESIA |
1 |
0.0003 |
| 148 |
RESPIRATORY RATE DECREASED |
1 |
0.0003 |
| 149 |
ELECTROENCEPHALOGRAM ABNORMAL |
1 |
0.0003 |
| 150 |
CARDIAC ARREST |
26 |
0.0003 |
| 151 |
VENTRICULAR HYPOKINESIA |
1 |
0.0003 |
| 152 |
ANGINA UNSTABLE |
2 |
0.0003 |
| 153 |
POSTURE ABNORMAL |
1 |
0.0003 |
| 154 |
NEAR DEATH EXPERIENCE |
1 |
0.0003 |
| 155 |
NUCLEAR MAGNETIC RESONANCE IMAGING ABNORMAL |
1 |
0.0003 |
| 156 |
LEFT VENTRICULAR DYSFUNCTION |
2 |
0.0003 |
| 157 |
SUPRAVENTRICULAR EXTRASYSTOLES |
1 |
0.0003 |
| 158 |
WRONG PRODUCT ADMINISTERED |
2 |
0.0003 |
| 159 |
HYPOTENSION |
59 |
0.0003 |
| 160 |
DROOLING |
2 |
0.0003 |
| 161 |
FUNCTIONAL GASTROINTESTINAL DISORDER |
1 |
0.0003 |
| 162 |
GRANULOMA |
1 |
0.0003 |
| 163 |
SYRINGE ISSUE |
5 |
0.0003 |
| 164 |
MUSCLE CONTRACTIONS INVOLUNTARY |
1 |
0.0003 |
| 165 |
HANGOVER |
1 |
0.0003 |
| 166 |
INCORRECT PRODUCT ADMINISTRATION DURATION |
6 |
0.0003 |
| 167 |
HYPERTENSIVE CRISIS |
3 |
0.0003 |
| 168 |
PROTEIN TOTAL DECREASED |
1 |
0.0003 |
| 169 |
SYSTEMIC INFLAMMATORY RESPONSE SYNDROME |
1 |
0.0003 |
| 170 |
PROCEDURAL COMPLICATION |
2 |
0.0003 |
| 171 |
EJECTION FRACTION DECREASED |
4 |
0.0003 |
| 172 |
POLYDIPSIA |
1 |
0.0003 |
| 173 |
AZOTAEMIA |
1 |
0.0003 |
| 174 |
ORGAN FAILURE |
1 |
0.0002 |
| 175 |
MUSCLE TIGHTNESS |
4 |
0.0002 |
| 176 |
EXTRAVASATION |
1 |
0.0002 |
| 177 |
INJECTION SITE EXTRAVASATION |
3 |
0.0002 |
| 178 |
RED CELL DISTRIBUTION WIDTH INCREASED |
1 |
0.0002 |
| 179 |
LIP OEDEMA |
1 |
0.0002 |
| 180 |
AORTIC VALVE INCOMPETENCE |
1 |
0.0002 |
| 181 |
INTERVERTEBRAL DISC DISORDER |
1 |
0.0002 |
| 182 |
LEFT VENTRICULAR HYPERTROPHY |
1 |
0.0002 |
| 183 |
ABNORMAL SENSATION IN EYE |
1 |
0.0002 |
| 184 |
ATRIOVENTRICULAR BLOCK FIRST DEGREE |
1 |
0.0002 |
| 185 |
MONOPLEGIA |
1 |
0.0002 |
| 186 |
DYSPHEMIA |
1 |
0.0002 |
| 187 |
PHYSICAL DISABILITY |
1 |
0.0002 |
| 188 |
LETHARGY |
13 |
0.0002 |
| 189 |
PAPILLOEDEMA |
1 |
0.0002 |
| 190 |
BLOOD PRESSURE DIASTOLIC INCREASED |
1 |
0.0002 |
| 191 |
CARDIO-RESPIRATORY ARREST |
9 |
0.0002 |
| 192 |
NEPHROPATHY |
2 |
0.0002 |
| 193 |
ARTERIOSCLEROSIS |
2 |
0.0002 |
| 194 |
ANGINA PECTORIS |
6 |
0.0002 |
| 195 |
SUBCUTANEOUS ABSCESS |
1 |
0.0002 |
| 196 |
SEIZURE |
24 |
0.0002 |
| 197 |
SINUS BRADYCARDIA |
2 |
0.0002 |
| 198 |
RENAL TUBULAR NECROSIS |
2 |
0.0002 |
| 199 |
HEART RATE INCREASED |
20 |
0.0002 |
| 200 |
CORONARY ARTERY STENOSIS |
1 |
0.0002 |
| 201 |
PETIT MAL EPILEPSY |
1 |
0.0002 |
| 202 |
CHEST DISCOMFORT |
20 |
0.0002 |
| 203 |
TENDERNESS |
2 |
0.0002 |
| 204 |
PARTIAL SEIZURES |
1 |
0.0002 |
| 205 |
SYNCOPE |
19 |
0.0002 |
| 206 |
SERUM FERRITIN INCREASED |
1 |
0.0002 |
| 207 |
CHEST PAIN |
35 |
0.0002 |
| 208 |
ANORECTAL DISCOMFORT |
1 |
0.0002 |
| 209 |
WHEEZING |
11 |
0.0002 |
| 210 |
BRUXISM |
1 |
0.0002 |
| 211 |
PALLOR |
5 |
0.0002 |
| 212 |
CHOKING SENSATION |
1 |
0.0002 |
| 213 |
GASTRIC ULCER HAEMORRHAGE |
1 |
0.0002 |
| 214 |
OBSTRUCTIVE AIRWAYS DISORDER |
2 |
0.0002 |
| 215 |
HEMIPARESIS |
3 |
0.0002 |
| 216 |
GENERALISED ERYTHEMA |
1 |
0.0002 |
| 217 |
NEUROLOGICAL SYMPTOM |
1 |
0.0002 |
| 218 |
SKIN WARM |
1 |
0.0002 |
| 219 |
COLD SWEAT |
3 |
0.0002 |
| 220 |
IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME |
1 |
0.0002 |
| 221 |
ATAXIA |
2 |
0.0002 |
| 222 |
MUSCLE RIGIDITY |
2 |
0.0002 |
| 223 |
PROTHROMBIN TIME PROLONGED |
1 |
0.0002 |
| 224 |
HEPATITIS B |
1 |
0.0002 |
| 225 |
BLOOD PRESSURE DECREASED |
11 |
0.0002 |
| 226 |
END STAGE RENAL DISEASE |
3 |
0.0002 |
| 227 |
TENSION |
1 |
0.0002 |
| 228 |
CHOLANGITIS |
1 |
0.0002 |
| 229 |
MULTIPLE INJURIES |
1 |
0.0002 |
| 230 |
ACUTE RESPIRATORY FAILURE |
3 |
0.0002 |
| 231 |
CORONARY ARTERY OCCLUSION |
2 |
0.0001 |
| 232 |
PERIPHERAL COLDNESS |
2 |
0.0001 |
| 233 |
RESPIRATION ABNORMAL |
1 |
0.0001 |
| 234 |
RESPIRATORY DISTRESS |
4 |
0.0001 |
| 235 |
SINUS TACHYCARDIA |
2 |
0.0001 |
| 236 |
RETCHING |
3 |
0.0001 |
| 237 |
PALPITATIONS |
16 |
0.0001 |
| 238 |
BLOOD PRESSURE DIASTOLIC DECREASED |
1 |
0.0001 |
| 239 |
HYDRONEPHROSIS |
1 |
0.0001 |
| 240 |
HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS |
1 |
0.0001 |
| 241 |
APHASIA |
4 |
0.0001 |
| 242 |
ECONOMIC PROBLEM |
2 |
0.0001 |
| 243 |
ANKLE FRACTURE |
2 |
0.0001 |
| 244 |
APNOEA |
1 |
0.0001 |
| 245 |
ELECTROCARDIOGRAM ABNORMAL |
1 |
0.0001 |
| 246 |
CYANOSIS |
2 |
0.0001 |
| 247 |
BLOOD ALBUMIN DECREASED |
1 |
0.0001 |
| 248 |
ATRIAL FLUTTER |
1 |
0.0001 |
| 249 |
SENSORY DISTURBANCE |
2 |
0.0001 |
| 250 |
PRODUCT SUBSTITUTION ISSUE |
7 |
0.0001 |
| 251 |
VENTRICULAR TACHYCARDIA |
2 |
0.0001 |
| 252 |
SPINAL COMPRESSION FRACTURE |
1 |
0.0001 |
| 253 |
GENERALISED TONIC-CLONIC SEIZURE |
2 |
0.0001 |
| 254 |
ACUTE CORONARY SYNDROME |
1 |
0.0001 |
| 255 |
SENSATION OF FOREIGN BODY |
1 |
0.0001 |
| 256 |
FACIAL PARALYSIS |
1 |
0.0001 |
| 257 |
LOSS OF CONSCIOUSNESS |
15 |
0.0001 |
| 258 |
CARDIAC MURMUR |
1 |
0.0001 |
| 259 |
PYELONEPHRITIS |
1 |
0.0001 |
| 260 |
SPINAL OSTEOARTHRITIS |
1 |
0.0001 |
| 261 |
ANAL INCONTINENCE |
1 |
0.0001 |
| 262 |
NERVE COMPRESSION |
1 |
0.0001 |
| 263 |
INTERVERTEBRAL DISC DEGENERATION |
1 |
0.0001 |
| 264 |
TUBULOINTERSTITIAL NEPHRITIS |
2 |
0.0001 |
| 265 |
FLANK PAIN |
1 |
0.0001 |
| 266 |
PAIN IN JAW |
3 |
0.0001 |
| 267 |
CHRONIC KIDNEY DISEASE |
8 |
0.0001 |
| 268 |
HYPERCHOLESTEROLAEMIA |
1 |
0.0001 |
| 269 |
ATELECTASIS |
1 |
0.0001 |
| 270 |
DIZZINESS POSTURAL |
1 |
0.0001 |
| 271 |
EAR PAIN |
2 |
0.0001 |
| 272 |
BLOOD PRESSURE SYSTOLIC INCREASED |
2 |
0.0001 |
| 273 |
TREMOR |
17 |
0.0001 |
| 274 |
HEPATOMEGALY |
1 |
0.0001 |
| 275 |
SINUS DISORDER |
2 |
0.0001 |
| 276 |
HYPERHIDROSIS |
13 |
0.0001 |
| 277 |
HAEMATOCRIT DECREASED |
2 |
0.0001 |
| 278 |
CORONARY ARTERY DISEASE |
3 |
0.0001 |
| 279 |
LIMB DISCOMFORT |
3 |
0.0001 |
| 280 |
PRODUCT QUALITY ISSUE |
13 |
0.0001 |
| 281 |
SPEECH DISORDER |
5 |
0.0001 |
| 282 |
INCONTINENCE |
1 |
0.0001 |
| 283 |
DECREASED ACTIVITY |
1 |
0.0001 |
| 284 |
DYSPNOEA |
52 |
0.0001 |
| 285 |
ANAPHYLACTIC REACTION |
5 |
0.0001 |
| 286 |
PULMONARY OEDEMA |
4 |
0.0001 |
| 287 |
SKIN INFECTION |
1 |
0.0001 |
| 288 |
OCULAR DISCOMFORT |
1 |
0.0001 |
| 289 |
BLOOD CALCIUM DECREASED |
1 |
0.0001 |
| 290 |
STATUS EPILEPTICUS |
1 |
0.0001 |
| 291 |
MITRAL VALVE INCOMPETENCE |
1 |
0.0001 |
| 292 |
MICTURITION URGENCY |
1 |
0.0001 |
| 293 |
EYELID OEDEMA |
1 |
0.0001 |
| 294 |
HEART RATE DECREASED |
3 |
0.0001 |
| 295 |
MYOCLONUS |
1 |
0.0001 |
| 296 |
HYPERLIPIDAEMIA |
1 |
0.0001 |
| 297 |
PARAESTHESIA |
13 |
0.0001 |
| 298 |
PLEURAL EFFUSION |
5 |
0.0001 |
| 299 |
NO THERAPEUTIC RESPONSE |
1 |
0.0001 |
| 300 |
GENERALISED OEDEMA |
1 |
0.0001 |
| 301 |
BLOOD ALKALINE PHOSPHATASE INCREASED |
2 |
0.0001 |
| 302 |
DERMATITIS ALLERGIC |
1 |
0.0001 |
| 303 |
MYDRIASIS |
1 |
0.0001 |
| 304 |
PULMONARY CONGESTION |
1 |
0.0001 |
| 305 |
DEPRESSED LEVEL OF CONSCIOUSNESS |
3 |
0.0001 |
| 306 |
EYE HAEMORRHAGE |
1 |
0.0001 |
| 307 |
QUALITY OF LIFE DECREASED |
1 |
0.0001 |
| 308 |
THROAT TIGHTNESS |
2 |
0.0001 |
| 309 |
TACHYPNOEA |
1 |
0.0001 |
| 310 |
NAUSEA |
57 |
0.0001 |
| 311 |
BLOOD PRESSURE INCREASED |
11 |
0.0001 |
| 312 |
HYPOMAGNESAEMIA |
1 |
0.0001 |
| 313 |
APHONIA |
1 |
0.0001 |
| 314 |
NECK PAIN |
4 |
0.0001 |
| 315 |
DEVICE OCCLUSION |
1 |
0.0001 |
| 316 |
SKIN REACTION |
1 |
0.0001 |
| 317 |
RED BLOOD CELL COUNT DECREASED |
2 |
0.0001 |
| 318 |
PARALYSIS |
1 |
0.0001 |
| 319 |
COMPLICATION ASSOCIATED WITH DEVICE |
1 |
0.0001 |
| 320 |
FLUID OVERLOAD |
1 |
0.0001 |
| 321 |
HEADACHE |
43 |
0.0001 |
| 322 |
DIZZINESS |
34 |
0.0001 |
| 323 |
TACHYCARDIA |
6 |
0.0001 |
| 324 |
PULMONARY MASS |
1 |
0.0001 |
| 325 |
BLOOD POTASSIUM DECREASED |
2 |
0.0001 |
| 326 |
OSTEOPENIA |
1 |
0.0001 |
| 327 |
VERTIGO |
4 |
0.0001 |
| 328 |
HYPOKALAEMIA |
3 |
0.0001 |
| 329 |
DEVICE RELATED INFECTION |
1 |
0.0001 |
| 330 |
MUSCULOSKELETAL CHEST PAIN |
1 |
0.0001 |
| 331 |
ABDOMINAL PAIN |
15 |
0.0001 |
| 332 |
ARRHYTHMIA |
3 |
0.0001 |
| 333 |
BLOOD LACTATE DEHYDROGENASE INCREASED |
1 |
0.0001 |
| 334 |
MIGRAINE |
6 |
0.0001 |
| 335 |
ABSCESS |
1 |
0.0001 |
| 336 |
CARDIAC FAILURE |
5 |
0.0001 |
| 337 |
ATRIAL FIBRILLATION |
6 |
0.0001 |
| 338 |
METASTASES TO BONE |
1 |
0.0001 |
| 339 |
MULTIPLE FRACTURES |
1 |
0.0001 |
| 340 |
INFUSION RELATED REACTION |
4 |
0.0001 |
| 341 |
ABDOMINAL DISCOMFORT |
10 |
0.0001 |
| 342 |
TRANSIENT ISCHAEMIC ATTACK |
2 |
0.0001 |
| 343 |
CEREBROVASCULAR ACCIDENT |
10 |
0.0001 |
| 344 |
MUSCULOSKELETAL DISCOMFORT |
1 |
0.0001 |
| 345 |
ORTHOSTATIC HYPOTENSION |
1 |
0.0001 |
| 346 |
DEVICE USE ISSUE |
1 |
0.0001 |
| 347 |
METASTASES TO LIVER |
1 |
0.0001 |
| 348 |
HYPOXIA |
2 |
0.0001 |
| 349 |
LYMPHOCYTE COUNT DECREASED |
1 |
0.0001 |
| 350 |
HEAD DISCOMFORT |
1 |
0.0001 |
| 351 |
DRUG ERUPTION |
1 |
0.0001 |
| 352 |
ISCHAEMIC STROKE |
1 |
0.0001 |
| 353 |
DEVICE ISSUE |
5 |
0.0001 |
| 354 |
ELECTROCARDIOGRAM QT PROLONGED |
2 |
0.0001 |
| 355 |
PELVIC PAIN |
1 |
0.0001 |
| 356 |
RESTLESS LEGS SYNDROME |
1 |
0.0001 |
| 357 |
PANIC ATTACK |
2 |
0.0001 |
| 358 |
EYE SWELLING |
2 |
0.0001 |
| 359 |
THINKING ABNORMAL |
1 |
0.0001 |
| 360 |
PHOTOPHOBIA |
1 |
0.0001 |
| 361 |
FRACTURE |
1 |
0.0001 |
| 362 |
RENAL FAILURE |
7 |
0.0001 |
| 363 |
MUSCULOSKELETAL DISORDER |
1 |
0.0001 |
| 364 |
SLEEP APNOEA SYNDROME |
1 |
0.0001 |
| 365 |
POST PROCEDURAL COMPLICATION |
1 |
0.0001 |
| 366 |
DYSTONIA |
1 |
0.0001 |
| 367 |
VOMITING |
24 |
0.0001 |
| 368 |
KIDNEY INFECTION |
1 |
0.0001 |
| 369 |
CYTOKINE RELEASE SYNDROME |
1 |
0.0000 |
| 370 |
DYSKINESIA |
2 |
0.0000 |
| 371 |
FLUSHING |
5 |
0.0000 |
| 372 |
DISCOMFORT |
3 |
0.0000 |
| 373 |
INJURY ASSOCIATED WITH DEVICE |
1 |
0.0000 |
| 374 |
OSTEOPOROSIS |
2 |
0.0000 |
| 375 |
TOOTH LOSS |
1 |
0.0000 |
| 376 |
PAIN IN EXTREMITY |
14 |
0.0000 |
| 377 |
IMPAIRED WORK ABILITY |
1 |
0.0000 |
| 378 |
SKIN CANCER |
1 |
0.0000 |
| 379 |
ALTERED STATE OF CONSCIOUSNESS |
1 |
0.0000 |
| 380 |
INTERVERTEBRAL DISC PROTRUSION |
1 |
0.0000 |
| 381 |
ANGIOEDEMA |
2 |
0.0000 |
| 382 |
HEART RATE IRREGULAR |
1 |
0.0000 |
| 383 |
ADVERSE EVENT |
4 |
0.0000 |
| 384 |
PERICARDIAL EFFUSION |
1 |
0.0000 |
| 385 |
INJURY |
3 |
0.0000 |
| 386 |
MOBILITY DECREASED |
3 |
0.0000 |
| 387 |
BLOOD GLUCOSE DECREASED |
2 |
0.0000 |
| 388 |
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES |
2 |
0.0000 |
| 389 |
CEREBRAL INFARCTION |
1 |
0.0000 |
| 390 |
ENCEPHALOPATHY |
1 |
0.0000 |
| 391 |
HYPOAESTHESIA |
6 |
0.0000 |
| 392 |
SOMNOLENCE |
8 |
0.0000 |
| 393 |
CARDIOVASCULAR DISORDER |
1 |
0.0000 |
| 394 |
ACUTE KIDNEY INJURY |
6 |
0.0000 |
| 395 |
DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS |
1 |
0.0000 |
| 396 |
ANAPHYLACTIC SHOCK |
1 |
0.0000 |
| 397 |
NO ADVERSE EVENT |
7 |
0.0000 |
| 398 |
HAEMATOMA |
1 |
0.0000 |
| 399 |
EXPOSURE VIA SKIN CONTACT |
1 |
0.0000 |
| 400 |
DIPLOPIA |
1 |
0.0000 |
| 401 |
INCORRECT DOSE ADMINISTERED BY DEVICE |
1 |
0.0000 |
| 402 |
ANHEDONIA |
1 |
0.0000 |
| 403 |
CARDIAC FAILURE CONGESTIVE |
3 |
0.0000 |
| 404 |
GAIT DISTURBANCE |
7 |
0.0000 |
| 405 |
RESPIRATORY ARREST |
1 |
0.0000 |
| 406 |
DIVERTICULITIS |
1 |
0.0000 |
| 407 |
FEELING COLD |
1 |
0.0000 |
| 408 |
DEMENTIA |
1 |
0.0000 |
| 409 |
INCORRECT DRUG ADMINISTRATION DURATION |
1 |
0.0000 |
| 410 |
HYPONATRAEMIA |
2 |
0.0000 |
| 411 |
ANXIETY |
10 |
0.0000 |
| 412 |
CONVULSION |
2 |
0.0000 |
| 413 |
BLOOD CREATINE PHOSPHOKINASE INCREASED |
1 |
0.0000 |
| 414 |
BACK PAIN |
8 |
0.0000 |
| 415 |
URINARY INCONTINENCE |
1 |
0.0000 |
| 416 |
RENAL INJURY |
1 |
0.0000 |
| 417 |
VISUAL IMPAIRMENT |
4 |
0.0000 |
| 418 |
SWOLLEN TONGUE |
1 |
0.0000 |
| 419 |
BONE DENSITY DECREASED |
1 |
0.0000 |
| 420 |
HYPOTHYROIDISM |
1 |
0.0000 |
| 421 |
METABOLIC ACIDOSIS |
1 |
0.0000 |
| 422 |
MOVEMENT DISORDER |
1 |
0.0000 |
| 423 |
DEEP VEIN THROMBOSIS |
2 |
0.0000 |
| 424 |
SWELLING FACE |
2 |
0.0000 |
| 425 |
INCORRECT DOSE ADMINISTERED |
7 |
0.0000 |
| 426 |
IMPAIRED HEALING |
1 |
0.0000 |
| 427 |
OSTEONECROSIS |
1 |
0.0000 |
| 428 |
STAPHYLOCOCCAL INFECTION |
1 |
0.0000 |
| 429 |
LIP SWELLING |
1 |
0.0000 |
| 430 |
SKIN DISORDER |
1 |
0.0000 |
| 431 |
GAIT INABILITY |
1 |
0.0000 |
| 432 |
MYOCARDIAL INFARCTION |
5 |
0.0000 |
| 433 |
BURNING SENSATION |
2 |
0.0000 |
| 434 |
HYPERKALAEMIA |
1 |
0.0000 |
| 435 |
HYPERTENSION |
6 |
0.0000 |
| 436 |
CRYING |
1 |
0.0000 |
| 437 |
DYSARTHRIA |
1 |
0.0000 |
| 438 |
DYSPNOEA EXERTIONAL |
1 |
0.0000 |
| 439 |
COLITIS |
1 |
0.0000 |
| 440 |
PERIPHERAL SWELLING |
4 |
0.0000 |
| 441 |
CHILLS |
3 |
0.0000 |
| 442 |
COUGH |
7 |
0.0000 |
| 443 |
EMOTIONAL DISTRESS |
3 |
0.0000 |
| 444 |
CONFUSIONAL STATE |
4 |
0.0000 |
| 445 |
DRY MOUTH |
2 |
0.0000 |
| 446 |
DEVICE BREAKAGE |
1 |
0.0000 |
| 447 |
ABDOMINAL PAIN UPPER |
5 |
0.0000 |
| 448 |
POLLAKIURIA |
1 |
0.0000 |
| 449 |
RENAL FAILURE ACUTE |
1 |
0.0000 |
| 450 |
RECTAL HAEMORRHAGE |
1 |
0.0000 |
| 451 |
DEVICE LEAKAGE |
1 |
0.0000 |
| 452 |
SEPTIC SHOCK |
1 |
0.0000 |
| 453 |
THERAPEUTIC RESPONSE UNEXPECTED |
1 |
0.0000 |
| 454 |
NEPHROLITHIASIS |
1 |
0.0000 |
| 455 |
MUSCLE SPASMS |
4 |
0.0000 |
| 456 |
TINNITUS |
1 |
0.0000 |
| 457 |
SKIN DISCOLOURATION |
1 |
0.0000 |
| 458 |
COGNITIVE DISORDER |
1 |
0.0000 |
| 459 |
WRONG TECHNIQUE IN DEVICE USAGE PROCESS |
1 |
0.0000 |
| 460 |
SWELLING |
2 |
0.0000 |
| 461 |
ASTHENIA |
8 |
0.0000 |
| 462 |
BLOOD GLUCOSE INCREASED |
4 |
0.0000 |
| 463 |
DISEASE RECURRENCE |
1 |
0.0000 |
| 464 |
COMA |
1 |
0.0000 |
| 465 |
FEELING ABNORMAL |
5 |
0.0000 |
| 466 |
CELLULITIS |
1 |
0.0000 |
| 467 |
HAEMOGLOBIN DECREASED |
2 |
0.0000 |
| 468 |
ERYTHEMA |
4 |
0.0000 |
| 469 |
CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
1 |
0.0000 |
| 470 |
ABDOMINAL DISTENSION |
2 |
0.0000 |
| 471 |
MUSCULOSKELETAL PAIN |
1 |
0.0000 |
| 472 |
PANCREATITIS |
1 |
0.0000 |
| 473 |
ASPARTATE AMINOTRANSFERASE INCREASED |
1 |
0.0000 |
| 474 |
INSOMNIA |
5 |
0.0000 |
| 475 |
DISTURBANCE IN ATTENTION |
1 |
0.0000 |
| 476 |
RASH PRURITIC |
1 |
0.0000 |
| 477 |
WHITE BLOOD CELL COUNT DECREASED |
2 |
0.0000 |
| 478 |
HAEMATOCHEZIA |
1 |
0.0000 |
| 479 |
MEDICATION ERROR |
1 |
0.0000 |
| 480 |
URTICARIA |
3 |
0.0000 |
| 481 |
OXYGEN SATURATION DECREASED |
1 |
0.0000 |
| 482 |
MUSCULAR WEAKNESS |
2 |
0.0000 |
| 483 |
GENERAL PHYSICAL HEALTH DETERIORATION |
2 |
0.0000 |
| 484 |
CONDITION AGGRAVATED |
5 |
0.0000 |
| 485 |
OEDEMA PERIPHERAL |
2 |
0.0000 |
| 486 |
FEELING HOT |
1 |
0.0000 |
| 487 |
ALANINE AMINOTRANSFERASE INCREASED |
1 |
0.0000 |
| 488 |
HYPERSENSITIVITY |
3 |
0.0000 |
| 489 |
INTENTIONAL OVERDOSE |
1 |
0.0000 |
| 490 |
BLOOD CREATININE INCREASED |
1 |
0.0000 |
| 491 |
DEHYDRATION |
2 |
0.0000 |
| 492 |
MULTIPLE SCLEROSIS RELAPSE |
1 |
0.0000 |
| 493 |
VISION BLURRED |
2 |
0.0000 |
| 494 |
MEMORY IMPAIRMENT |
2 |
0.0000 |
| 495 |
DIARRHOEA |
9 |
0.0000 |
| 496 |
RESPIRATORY FAILURE |
1 |
0.0000 |
| 497 |
MALAISE |
6 |
0.0000 |
| 498 |
AGITATION |
1 |
0.0000 |
| 499 |
DEPRESSION |
3 |
0.0000 |
| 500 |
PAIN |
8 |
0.0000 |
| 501 |
DRUG DOSE OMISSION BY DEVICE |
1 |
0.0000 |
| 502 |
ARTHRITIS |
1 |
0.0000 |
| 503 |
INJECTION SITE BRUISING |
1 |
0.0000 |
| 504 |
INJECTION SITE HAEMORRHAGE |
1 |
0.0000 |
| 505 |
DRUG ABUSE |
1 |
0.0000 |
| 506 |
BALANCE DISORDER |
1 |
0.0000 |
| 507 |
FATIGUE |
9 |
0.0000 |
| 508 |
MUSCULOSKELETAL STIFFNESS |
1 |
0.0000 |
| 509 |
GASTROINTESTINAL DISORDER |
1 |
0.0000 |
| 510 |
ADVERSE DRUG REACTION |
1 |
0.0000 |
| 511 |
NASOPHARYNGITIS |
2 |
0.0000 |
| 512 |
CARDIAC DISORDER |
1 |
0.0000 |
| 513 |
DRUG INEFFECTIVE |
14 |
0.0000 |
| 514 |
DYSPHAGIA |
1 |
0.0000 |
| 515 |
ANAEMIA |
2 |
0.0000 |
| 516 |
PRURITUS |
4 |
0.0000 |
| 517 |
ILLNESS |
1 |
0.0000 |
| 518 |
HAEMORRHAGE |
1 |
0.0000 |
| 519 |
PLATELET COUNT DECREASED |
1 |
0.0000 |
| 520 |
RASH |
4 |
0.0000 |
| 521 |
SEPSIS |
1 |
0.0000 |
| 522 |
ASTHMA |
1 |
0.0000 |
| 523 |
INJECTION SITE ERYTHEMA |
1 |
0.0000 |
| 524 |
OFF LABEL USE |
7 |
0.0000 |
| 525 |
PSORIASIS |
1 |
0.0000 |
| 526 |
ARTHRALGIA |
3 |
0.0000 |
| 527 |
DRUG INTERACTION |
1 |
0.0000 |
| 528 |
DRUG DEPENDENCE |
1 |
0.0000 |
| 529 |
FALL |
2 |
0.0000 |
| 530 |
URINARY TRACT INFECTION |
1 |
0.0000 |
| 531 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
1 |
0.0000 |
| 532 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
1 |
0.0000 |
| 533 |
CONSTIPATION |
1 |
0.0000 |
| 534 |
INJECTION SITE PAIN |
1 |
0.0000 |
| 535 |
DEATH |
1 |
0.0000 |